1–20 of 191 hits

Sort by: Relevancy | Date newest | Title A-Z

  1.  

    Analytical challenges in quantifying abiraterone with LC–MS/MS in human plasma

    Benoist, Guillemette E. / van der Meulen, Eric / Lubberman, Floor J.E. et al. | Wiley | 2017
    Keywords: abiraterone, abiraterone acetate
  2.  

    The interactions of a number of steroid-metabolizing cytochromes P450 with abiraterone D4A metabolite: spectral analysis and molecular docking

    Masamrekh, Rami A. / Filippova, Tatiana A. / Haurychenka, Yaraslau I. et al. | Elsevier | 2020
    Keywords: Abiraterone, Abiraterone metabolite
  3.  

    Retreatment of men with metastatic castrate‐resistant prostate cancer with abiraterone

    Leibowitz‐Amit, Raya / Alimohamed, Nimira / Vera‐Badillo, Francisco E. et al. | Wiley | 2014
    Keywords: abiraterone
  4.  

    Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity

    Bedussi, Francesca / Galli, Diego / Fragni, Martina et al. | Karger Verlag | 2017
    Keywords: Abiraterone
  5.  

    Estimation of the inhibiting impact of abiraterone D4A metabolite on human steroid 21-monooxygenase (CYP21A2)

    Masamrekh, Rami / Filippova, Tatiana / Haurychenka, Yaraslau et al. | Elsevier | 2019
    Keywords: Abiraterone D4A metabolite
  6.  

    Recognition and Treatment of Adrenal Insufficiency Secondary to Abiraterone: A Case Report and Literature Review

    Baloch, Harris M. / Grice-Patil, Zachary Joseph / Selig, Daniel Jaaron et al. | Karger Verlag | 2019
    Keywords: Abiraterone
  7.  

    Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden

    Franck Lissbrant, Ingela / Ventimiglia, Eugenio / Robinson, David et al. | Taylor & Francis Verlag | 2018
    Keywords: Abiraterone
  8.  

    Abiraterone or Enzalutamide in Advanced Castration‐Resistant Prostate Cancer: An Indirect Comparison

    Chopra, Akhil / Georgieva, Mina / Lopes, Gilberto et al. | Wiley | 2017
    Keywords: abiraterone
  9.  

    Clinical activity of enzalutamide versus docetaxel in men with castration‐resistant prostate cancer progressing after abiraterone

    Suzman, Daniel L. / Luber, Brandon / Schweizer, Michael T. et al. | Wiley | 2014
    Keywords: abiraterone
  10.  

    A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone

    Silveira, Rafael G. / Cunha, Beatriz N. / Tenório, Juan C. et al. | Elsevier | 2019
    Keywords: Abiraterone
  11.  

    Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer

    Chi, Kim N. / Spratlin, Jennifer / Kollmannsberger, Christian et al. | Wiley | 2015
    Keywords: abiraterone acetate
  12.  

    Synthesis and anticancer properties of RGD peptides conjugated to nitric oxide releasing functional groups and abiraterone

    Nortcliffe, Andrew / Fleming, Ian N. / Botting, Nigel P. et al. | Elsevier | 2014
    Keywords: Abiraterone
  13.  

    CYP17A1 and Androgen-Receptor Expression in Prostate Carcinoma Tissues and Cancer Cell Lines

    Giatromanolaki, Alexandra / Fasoulaki, Virginia / Kalamida, Dimitra et al. | Karger Verlag | 2019
    Keywords: Abiraterone
  14.  

    Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposures

    Li, Claire H. / Sherer, Eric A. / Lewis, Lionel D. et al. | Wiley | 2015
    Keywords: abiraterone
  15.  

    A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration‐resistant prostate cancer

    McKay, Rana R. / Werner, Lillian / Jacobus, Susanna J. et al. | Wiley | 2019
    Keywords: abiraterone
  16.  

    Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer

    De Laere, Bram / Oeyen, Steffi / Van Oyen, Peter et al. | Wiley | 2018
    Keywords: abiraterone
  17.  

    Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC).

    Bremmer, Felix / Jarry, Hubertus / Strauß, Arne et al. | BASE
    Keywords: Abiraterone acetate; CYP17A1; CRPC; Androgen receptor; IGF-2

Number of results: 10 | 20 | 50

Feedback